J&J’s new bladder cancer treatment, TAR-200, is making waves! Over 80% of patients stayed disease-free without needing extra treatments, and a whopping 94% kept their bladders—no radical surgery required. Early results show it’s safe and effective, with most side effects being mild. If the next trial goes well, this could totally change how bladder cancer is treated. Would you try a new therapy if it meant skipping major surgery? #BladderCancer #MedicalBreakthrough #CancerResearch #HealthcareInnovation #Health